Resmetirom: A Breakthrough in the Treatment of Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD)

Laiba Shakeel(Dow University of Health Sciences), Aymar Akilimali, Ayesha Shaukat(Dow University of Health Sciences)
Health Science Reports
June 1, 2025
Cited by 9


Related Papers